Autolus Therapeutics plc (AUTL) NASDAQ

1.84

+0.06(+3.37%)

Updated at August 18 02:43PM

Currency In USD

Valuation

Market Cap599.63M
Enterprise Value424.88M
P/E Ratio-2.06
PEG Ratio0.9
Price/Sales Ratio54.34
Price/Book Ratio1.32
Enterprise/Revenue50.11
Enterprise/EBITDA-1.92

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-26.43
Operating Margin-29.73

Management Effectiveness

Return On Assets-0.32
Return On Equity-0.53

Income Statement

Revenue10.12M
Revenue/Share0.03
Gross Profit-1.27M
EBITDA-182.42M
Net Income-220.66M
Diluted EPS-0.86

Balance Sheet

Total Cash516.58M
Total Cash/Share1.94
Total Debt57.71M
Total Debt/Equity0.16
Current Ratio9.24
Book Value Per Share1.39

Price History

52-Week Change-52.08
52-Week High5
52-Week Low1.11
Moving Average 50 Days2.32
Moving Average 200 Days2.19

Statistics

Average Volume2.2M
Shares Outstanding266.13M
% Held by Institutions56.88

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A